Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9321797rdf:typepubmed:Citationlld:pubmed
pubmed-article:9321797lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C0027054lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C1516518lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:9321797lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:9321797pubmed:issue3 Pt 2lld:pubmed
pubmed-article:9321797pubmed:dateCreated1997-10-23lld:pubmed
pubmed-article:9321797pubmed:abstractTextReperfusion of ischemic rat hearts initiates the generation of inositol(1,4,5)trisphosphate [Ins(1,4,5)P3] and arrhythmias, provided that either norepinephrine or thrombin is present. In the current study, effects on endothelin-1 (ET-1) responses were investigated. Reperfusion of catecholamine-depleted, [3H]inositol-labeled hearts in the presence of ET-1 caused an increase in [3H]inositol phosphates (7,073 +/- 1,004 to 17,300 +/- 206 counts.min-1.g tissue-1, means +/- SE, n = 4, P < 0.01), which was quantitatively greater than the release observed under normoxic conditions, but there was no increase in [3H]Ins(1,4,5)P3. Gentamicin (150 microM) inhibited inositol phosphate responses in the presence of either norepinephrine or thrombin but did not inhibit the response to ET-1, providing additional evidence that the inositol phosphate response to ET-1 does not involve formation of Ins(1,4,5)P3, even under reperfusion conditions. In contrast to norepinephrine and thrombin, ET-1 did not initiate reperfusion arrhythmias (4.4% ventricular fibrillation compared with 0% ventricular fibrillation in catecholamine-depleted controls). The data provide strong evidence that the effect of ischemia-reperfusion on inositol phosphate responses is specific for particular receptor types and eliminates G proteins, phospholipase C enzymes, and substrate availability as the primary factors responsible for Ins(1,4,5)P3 generation under reperfusion conditions.lld:pubmed
pubmed-article:9321797pubmed:languageenglld:pubmed
pubmed-article:9321797pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9321797pubmed:citationSubsetIMlld:pubmed
pubmed-article:9321797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9321797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9321797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9321797pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9321797pubmed:statusMEDLINElld:pubmed
pubmed-article:9321797pubmed:monthSeplld:pubmed
pubmed-article:9321797pubmed:issn0002-9513lld:pubmed
pubmed-article:9321797pubmed:authorpubmed-author:WoodcockE AEAlld:pubmed
pubmed-article:9321797pubmed:authorpubmed-author:JacobsenA NANlld:pubmed
pubmed-article:9321797pubmed:authorpubmed-author:DuX JXJlld:pubmed
pubmed-article:9321797pubmed:authorpubmed-author:DartA MAMlld:pubmed
pubmed-article:9321797pubmed:issnTypePrintlld:pubmed
pubmed-article:9321797pubmed:volume273lld:pubmed
pubmed-article:9321797pubmed:ownerNLMlld:pubmed
pubmed-article:9321797pubmed:authorsCompleteYlld:pubmed
pubmed-article:9321797pubmed:paginationH1119-25lld:pubmed
pubmed-article:9321797pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:meshHeadingpubmed-meshheading:9321797-...lld:pubmed
pubmed-article:9321797pubmed:year1997lld:pubmed
pubmed-article:9321797pubmed:articleTitleIns(1,4,5)P3 and arrhythmogenic responses during myocardial reperfusion: evidence for receptor specificity.lld:pubmed
pubmed-article:9321797pubmed:affiliationCellular Biochemistry Laboratory, Baker Medical Research Institute, Prahran, Melbourne, Australia.lld:pubmed
pubmed-article:9321797pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9321797pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9321797pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9321797lld:pubmed